Evidence map›Paper›PMID 39897984›Full record

ArticleBMJ open sport & exercise medicine2025

The Cambridge Knee Injury Tool (CamKIT): a clinical prediction tool for acute soft tissue knee injuries.

Thomas Molloy, Benjamin Gompels, Simone Castagno, Stephen McDonnell

Erratum issuedAbstract read
In one paragraph

Article in BMJ open sport & exercise medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Thomas MolloyDivision of Trauma and Orthopaedic Surgery, University of Cambridge, Cambridge, UK.ORCID 0009-0007-2510-4972
Benjamin GompelsDivision of Trauma and Orthopaedic Surgery, University of Cambridge, Cambridge, UK.
Simone CastagnoDivision of Trauma and Orthopaedic Surgery, University of Cambridge, Cambridge, UK.
Stephen McDonnellDivision of Trauma and Orthopaedic Surgery, University of Cambridge, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: This study focuses on the development of the Cambridge Knee Injury Tool (CamKIT), a clinical prediction tool developed as a 12-point scoring tool based on a modified e-Delphi study. Methods: A retrospective cohort evaluation was conducted involving 229 patients presenting to a Major Trauma Centre with acute knee pain over 3 months. The evaluation extracted data on the 12 scoring tool variables as well as diagnostic and management pathway outcomes. CamKIT scores for the injured and non-injured cohorts were then calculated and evaluated. Results: The CamKIT yielded a median score of 7.5 (IQR: 6-9) in the injured cohort, compared with a median score of 2 (IQR: 1-4) in the non-injured cohort, with a statistically significant difference (p<0.0001). When constructed as a three-tier risk stratification tool, the CamKIT produces a sensitivity of 100%, a specificity of 94.3%, a positive predictive value of 89% and a negative predictive value of 100% for diagnosing clinically significant soft tissue knee injuries. Conclusion: The CamKIT provides a non-invasive tool that has the potential to streamline the diagnostic process and empower healthcare workers in resource-stretched settings by instilling confidence and promoting accuracy in clinical decision-making. The CamKIT also has the potential to support efficiency in the secondary healthcare setting by enabling more targeted and timely use of specialist resources. This research contributes to the ongoing efforts to enhance patient outcomes and the overall quality of care in managing acute knee injuries.

Indexed as

DiagnosisInjuryKnee injuriesLigamentSoft tissue

Identifiers

PMID39897984
PMCPMC11780958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.